What question did this study set out to answer?

This study aims to compare awareness and utilization of T-cell redirecting therapies among patients with multiple myeloma, focusing on racial disparities.

July 29, 2026CancersOpen Access

Access to T-Cell Redirecting Therapies in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives on Awareness and Barriers

View Full Paper

Ask AI

Bookmark

Authors

ZSZalak Shah MRMyra Robinson APAbena Prempeh

Discussion

Member takes

Overview

Cross-sectional study reveals significant awareness and access barriers to T-cell therapies in multiple myeloma, indicating a need for targeted educational efforts.

Key Points

This study aims to compare awareness and utilization of T-cell redirecting therapies among patients with multiple myeloma, focusing on racial disparities.
Cross-sectional study using IRB-approved surveys distributed to patients, caregivers, and physicians from June to September 2025.
Surveys assessed familiarity, perceived barriers, and access challenges regarding TCRT.
Total respondents: 428 (346 patients, 51 caregivers, 31 physicians).
26% of respondents were unfamiliar with TCRTs, with higher unawareness in Black patients (32%).
Among treated patients, TCRT utilization was similar across racial groups (39% Black vs. 38% non-Black).
71% of physicians referred patients for TCRT, but only 48% of referrals led to treatment, primarily due to patient hesitancy.

Cite This Study

Shah et al. (2026) studied this question.

synapsesocial.com/papers/6a69a26dc8da07d9defa5d62 https://doi.org/10.3390/cancers18152412

View Full Paper

Ask AI

Bookmark

July 29, 2026CancersOpen Access

Access to T-Cell Redirecting Therapies in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives on Awareness and Barriers

View Full Paper

Ask AI

Bookmark

Authors

ZSZalak Shah MRMyra Robinson APAbena Prempeh

Discussion

Member takes

Overview

Cross-sectional study reveals significant awareness and access barriers to T-cell therapies in multiple myeloma, indicating a need for targeted educational efforts.

Key Points

This study aims to compare awareness and utilization of T-cell redirecting therapies among patients with multiple myeloma, focusing on racial disparities.
Cross-sectional study using IRB-approved surveys distributed to patients, caregivers, and physicians from June to September 2025.
Surveys assessed familiarity, perceived barriers, and access challenges regarding TCRT.
Total respondents: 428 (346 patients, 51 caregivers, 31 physicians).
26% of respondents were unfamiliar with TCRTs, with higher unawareness in Black patients (32%).
Among treated patients, TCRT utilization was similar across racial groups (39% Black vs. 38% non-Black).
71% of physicians referred patients for TCRT, but only 48% of referrals led to treatment, primarily due to patient hesitancy.

Cite This Study

Shah et al. (2026) studied this question.

synapsesocial.com/papers/6a69a26dc8da07d9defa5d62 https://doi.org/10.3390/cancers18152412

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark